MedTrace Logo

Foot/Hand Neuromodulation for Overactive Bladder (OAB)

NCT01972061 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2020-02-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine if electrical stimulation of the foot is effective in the treatment of overactive bladder conditions.

Conditions

Interventions

DEVICE

Foot stimulation

Foot stimulation electrically activates the somatic afferent nerves in the foot using FDA-approved, commercially available transcutaneous electrical nerve stimulator (TENS) and skin surface electrodes attached to the foot.

Sponsors & Collaborators

  • Christopher J Chermansky, MD

    lead OTHER

Principal Investigators

  • Christopher Chermansky, MD · University of Pittsburgh

  • Dawn McBride, RN · University of Pittsburgh

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2018-12-11
Completion
2018-12-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01972061 on ClinicalTrials.gov